Page last updated: 2024-10-26

pentetic acid and Ewing Sarcoma

pentetic acid has been researched along with Ewing Sarcoma in 5 studies

Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.

Research Excerpts

ExcerptRelevanceReference
"The ability of dynamic, gadolinium-enhanced magnetic resonance (MR) imaging to allow prediction of histologic responses to initial chemotherapy was evaluated in 20 patients with osteosarcoma (n = 12), Ewing sarcoma (n = 4), rhabdomyosarcoma (n = 3), or synovial sarcoma (n = 1)."3.68Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy. ( Fairclough, DL; Fletcher, BD; Gronemeyer, SA; Hanna, SL, 1992)
"In nine patients with osteogenic or Ewing sarcoma, we evaluated the use of magnetic resonance angiography (MRA) to assess neovascularity non-invasively in vivo and to monitor response to chemotherapy."2.68Monitoring neovascularity as an indicator to response to chemotherapy in osteogenic and Ewing sarcoma using magnetic resonance angiography. ( Genant, HK; Gooding, CA; Johnston, JO; Lang, P; Matthay, KK; Rosenau, W; Vahlensieck, M, 1996)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van der Woude, HJ1
Bloem, JL1
Verstraete, KL1
Taminiau, AH1
Nooy, MA1
Hogendoorn, PC1
Lang, P1
Vahlensieck, M1
Matthay, KK1
Johnston, JO1
Rosenau, W1
Gooding, CA1
Genant, HK1
Fletcher, BD2
Hanna, SL2
Fairclough, DL1
Gronemeyer, SA2
Langston, JW1
Maas, R1
Winkler, K1
Delling, G1
Heise, U1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Randomised Controlled Trial of the Effects of Fish Oil Emulsion in Total Parenteral Nutrition Upon Tumour Vascularity in Patients With Hepatic Colorectal Metastases[NCT00942292]Phase 220 participants (Actual)Interventional2007-05-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for pentetic acid and Ewing Sarcoma

ArticleYear
Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery.
    AJR. American journal of roentgenology, 1995, Volume: 165, Issue:3

    Topics: Adolescent; Adult; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Contrast Media; Drug Combinations;

1995
Monitoring neovascularity as an indicator to response to chemotherapy in osteogenic and Ewing sarcoma using magnetic resonance angiography.
    Medical and pediatric oncology, 1996, Volume: 26, Issue:5

    Topics: Adolescent; Antineoplastic Agents; Bone Neoplasms; Double-Blind Method; Female; Gadolinium DTPA; Hum

1996

Other Studies

3 other studies available for pentetic acid and Ewing Sarcoma

ArticleYear
Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy.
    Radiology, 1992, Volume: 184, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Contrast M

1992
Subtraction technique for contrast-enhanced MR images of musculoskeletal tumors.
    Magnetic resonance imaging, 1990, Volume: 8, Issue:3

    Topics: Bone Neoplasms; Child; Evaluation Studies as Topic; Gadolinium DTPA; Humans; Magnetic Resonance Imag

1990
The potential of MRI in preoperative evaluation of chemotherapy-induced necrosis in osteosarcoma and Ewing's sarcoma.
    La Chirurgia degli organi di movimento, 1990, Volume: 75, Issue:1 Suppl

    Topics: Bone Neoplasms; Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Necrosis; Organ

1990